Rhodes Jason P

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17.9M
Net Open-Market Flow
-$17.9M
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)5K$23.61$118K3K
Jul 7, 2026Sell(S)15K$23.62$351K1.1M
Jul 7, 2026Sell(S)49K$23.17$1.1M827K
Jul 7, 2026Sell(S)12K$23.62$276K815K
Jul 7, 2026Sell(S)124K$23.17$2.9M4.1M
Jul 7, 2026Sell(S)30K$23.62$699K4.1M
Jul 7, 2026Sell(S)63K$23.17$1.4M1.2M
Jul 6, 2026Sell(S)127K$22.79$2.9M1.2M
Jul 6, 2026Sell(S)100K$22.79$2.3M876K
Jul 6, 2026Sell(S)253K$22.79$5.8M4.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001577014-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly: